Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Immunogenicity and protective efficacy in dogs of an MF59™-adjuvanted vaccine against recombinant canine/porcine coronavirus.

Decaro N, Mari V, Sciarretta R, Colao V, Losurdo M, Catella C, Elia G, Martella V, Del Giudice G, Buonavoglia C.

Vaccine. 2011 Mar 3;29(11):2018-23. doi: 10.1016/j.vaccine.2011.01.028. Epub 2011 Jan 25.

PMID:
21272607
2.

Safety and efficacy of a modified-live canine coronavirus vaccine in dogs.

Pratelli A, Tinelli A, Decaro N, Martella V, Camero M, Tempesta M, Martini M, Carmichael LE, Buonavoglia C.

Vet Microbiol. 2004 Mar 26;99(1):43-9.

PMID:
15019110
3.

Efficacy of an inactivated canine coronavirus vaccine in pups.

Pratelli A, Tinelli A, Decaro N, Cirone F, Elia G, Roperto S, Tempesta M, Buonavoglia C.

New Microbiol. 2003 Apr;26(2):151-5.

PMID:
12737196
4.

High-cell-passage canine coronavirus vaccine providing sterilising immunity.

Pratelli A.

J Small Anim Pract. 2007 Oct;48(10):574-8.

PMID:
17877547
5.

Immunity after natural exposure to enteric canine coronavirus does not provide complete protection against infection with the new pantropic CB/05 strain.

Decaro N, Elia G, Martella V, Campolo M, Mari V, Desario C, Lucente MS, Lorusso E, Kanellos T, Gibbons RH, Buonavoglia C.

Vaccine. 2010 Jan 8;28(3):724-9. doi: 10.1016/j.vaccine.2009.10.077. Epub 2009 Nov 1.

PMID:
19887130
6.

An ELISA based on recombinant spike protein S for the detection of antibodies to transmissible gastroenteritis virus of swine-like canine coronaviruses.

Elia G, Decaro N, Martella V, Lorusso E, Mari V, Maria SL, Cordioli P, Buonavoglia C.

J Virol Methods. 2010 Feb;163(2):309-12. doi: 10.1016/j.jviromet.2009.10.015. Epub 2009 Oct 28.

PMID:
19878695
7.

Prevalence of canine coronavirus antibodies by an enzyme-linked immunosorbent assay in dogs in the south of Italy.

Pratelli A, Elia G, Martella V, Palmieri A, Cirone F, Tinelli A, Corrente M, Buonavoglia C.

J Virol Methods. 2002 Apr;102(1-2):67-71.

PMID:
11879694
8.

Experimental infection of dogs with a novel strain of canine coronavirus causing systemic disease and lymphopenia.

Decaro N, Campolo M, Lorusso A, Desario C, Mari V, Colaianni ML, Elia G, Martella V, Buonavoglia C.

Vet Microbiol. 2008 Apr 30;128(3-4):253-60. Epub 2007 Oct 18.

PMID:
18031959
9.

Isolation, tissue distribution and molecular characterization of two recombinant canine coronavirus strains.

Ntafis V, Mari V, Decaro N, Papanastassopoulou M, Papaioannou N, Mpatziou R, Buonavoglia C, Xylouri E.

Vet Microbiol. 2011 Aug 5;151(3-4):238-44. doi: 10.1016/j.vetmic.2011.03.008. Epub 2011 Mar 16.

PMID:
21481551
10.

Recombinant canine coronaviruses in dogs, Europe.

Decaro N, Mari V, Elia G, Addie DD, Camero M, Lucente MS, Martella V, Buonavoglia C.

Emerg Infect Dis. 2010 Jan;16(1):41-7. doi: 10.3201/eid1601.090726.

11.

Detection and genotyping of canine coronavirus RNA in diarrheic dogs in Japan.

Soma T, Ohinata T, Ishii H, Takahashi T, Taharaguchi S, Hara M.

Res Vet Sci. 2011 Apr;90(2):205-7. doi: 10.1016/j.rvsc.2010.05.027. Epub 2010 Jun 16.

PMID:
20557915
12.

Fecal immunoglobulin A antibodies in dogs infected or vaccinated with canine coronavirus.

Decaro N, Pratelli A, Tinelli A, Martella V, Camero M, Buonavoglia D, Tempesta M, Caroli AM, Buonavoglia C.

Clin Diagn Lab Immunol. 2004 Jan;11(1):102-5.

13.

Canine viral vaccines at a turning point--a personal perspective.

Carmichael LE.

Adv Vet Med. 1999;41:289-307. Review.

PMID:
9890023
14.

Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.

Siedek EM, Schmidt H, Sture GH, Raue R.

Berl Munch Tierarztl Wochenschr. 2011 Jan-Feb;124(1-2):58-64.

PMID:
21306055
15.

Protective efficacy and immunogenicity of an inactivated avian-origin H3N2 canine influenza vaccine in dogs challenged with the virulent virus.

Lee C, Jung K, Oh J, Oh T, Han S, Hwang J, Yeom M, Son D, Kim J, Park B, Moon H, Song D, Kang B.

Vet Microbiol. 2010 Jul 14;143(2-4):184-8. doi: 10.1016/j.vetmic.2009.11.037. Epub 2009 Dec 4.

PMID:
20034748
16.

Genetic evolution of canine coronavirus and recent advances in prophylaxis.

Pratelli A.

Vet Res. 2006 Mar-Apr;37(2):191-200. Review.

17.

Cloning and expression of two fragments of the S gene of canine coronavirus type I.

Pratelli A, Elia G, Decaro N, Tola S, Tinelli A, Martella V, Rocca S, Tempesta M, Buonavoglia C.

J Virol Methods. 2004 Apr;117(1):61-5.

PMID:
15019260
18.

Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.

Campos FS, Dezen D, Antunes DA, Santos HF, Arantes TS, Cenci A, Gomes F, Lima FE, Brito WM, Filho HC, Batista HB, Spilki FR, Franco AC, Rijsewijk FA, Roehe PM.

Vet Microbiol. 2011 Feb 24;148(1):18-26. doi: 10.1016/j.vetmic.2010.08.004. Epub 2010 Aug 17.

PMID:
20828945
19.

Canine coronavirus infection in Turkish dog population.

Yeşilbağ K, Yilmaz Z, Torun S, Pratelli A.

J Vet Med B Infect Dis Vet Public Health. 2004 Sep;51(7):353-5.

PMID:
15525364
20.

Evaluation of the efficacy of a canine influenza virus (H3N8) vaccine in dogs following experimental challenge.

Deshpande MS, Jirjis FF, Tubbs AL, Jayappa H, Sweeney D, Spencer SJ, Lakshmanan N, Wasmoen TL.

Vet Ther. 2009 Fall;10(3):103-12.

PMID:
20037964

Supplemental Content

Support Center